Literature DB >> 22729838

Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex.

Allison S Harney1, Laura B Sole, Thomas J Meade.   

Abstract

Cobalt(III) Schiff base complexes have been used as potent inhibitors of protein function through the coordination to histidine residues essential for activity. The kinetics and thermodynamics of the binding mechanism of Co(acacen)(NH(3))(2)Cl [Co(acacen); where H(2)acacen is bis(acetylacetone)ethylenediimine] enzyme inhibition has been examined through the inactivation of matrix metalloproteinase 2 (MMP-2) protease activity. Co(acacen) is an irreversible inhibitor that exhibits time- and concentration-dependent inactivation of MMP-2. Co(acacen) inhibition of MMP-2 is temperature-dependent, with the inactivation increasing with temperature. Examination of the formation of the transition state for the MMP-2/Co(acacen) complex was determined to have a positive entropy component indicative of greater disorder in the MMP-2/Co(acacen) complex than in the reactants. With further insight into the mechanism of Co(acacen) complexes, Co(III) Schiff base complex protein inactivators can be designed to include features regulating activity and protein specificity. This approach is widely applicable to protein targets that have been identified to have clinical significance, including matrix metalloproteinases. The mechanistic information elucidated here further emphasizes the versatility and utility of Co(III) Schiff base complexes as customizable protein inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729838      PMCID: PMC3418067          DOI: 10.1007/s00775-012-0902-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  24 in total

Review 1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

2.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

Review 3.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

Authors:  Christopher M Overall; Oded Kleifeld
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

4.  Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate.

Authors:  Ryan R Hurtado; Allison S Harney; Marie C Heffern; Robert J Holbrook; Robert A Holmgren; Thomas J Meade
Journal:  Mol Pharm       Date:  2012-01-20       Impact factor: 4.939

5.  Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.

Authors:  T Takeuchi; A Böttcher; C M Quezada; T J Meade; H B Gray
Journal:  Bioorg Med Chem       Date:  1999-05       Impact factor: 3.641

Review 6.  Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

Authors:  Anna Morancho; Anna Rosell; Lidia García-Bonilla; Joan Montaner
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Isolation of a myoglobin molten globule by selective cobalt(III)-induced unfolding.

Authors:  O Blum; A Haiek; D Cwikel; Z Dori; T J Meade; H B Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions.

Authors:  Natalia Díaz; Dimas Suarez
Journal:  Biochemistry       Date:  2007-07-07       Impact factor: 3.162

9.  Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.

Authors:  Jonas Hansson; Ramachandran S Vasan; Johan Ärnlöv; Erik Ingelsson; Lars Lind; Anders Larsson; Karl Michaëlsson; Johan Sundström
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

Review 10.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

View more
  7 in total

1.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

Review 2.  Cobalt derivatives as promising therapeutic agents.

Authors:  Marie C Heffern; Natsuho Yamamoto; Robert J Holbrook; Amanda L Eckermann; Thomas J Meade
Journal:  Curr Opin Chem Biol       Date:  2012-12-24       Impact factor: 8.822

3.  Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Authors:  Lisa M Manus; Robert J Holbrook; Tulay A Atesin; Marie C Heffern; Allison S Harney; Amanda L Eckermann; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-01-02       Impact factor: 5.165

4.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

5.  Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.

Authors:  Marie C Heffern; Viktorie Reichova; Joseph L Coomes; Allison S Harney; Elizabeth A Bajema; Thomas J Meade
Journal:  Inorg Chem       Date:  2015-09-02       Impact factor: 5.165

6.  Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.

Authors:  Mark D Peterson; Robert J Holbrook; Thomas J Meade; Emily A Weiss
Journal:  J Am Chem Soc       Date:  2013-08-23       Impact factor: 15.419

7.  Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity.

Authors:  Mingfeng Yu; Ngee H Lim; Samantha Ellis; Hideaki Nagase; James A Triccas; Peter J Rutledge; Matthew H Todd
Journal:  ChemistryOpen       Date:  2013-06-12       Impact factor: 2.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.